Table 1.
Measurable outcomes and their collection timepoints (TP).
| Measurable outcome | Contact point measurement | |||
|---|---|---|---|---|
| TP1 | TP2 | TP3 | TP4 | |
| Clinical history | x | |||
| Anthropometric measurements (body weight, waist circumference, BMI) | x | x | x | x |
| Biochemistry measurements* | x | x | x | |
| Step count (using Fitbit wearable fitness tracker) ** | x | x | x | x |
| Questionnaires | ||||
| International Physical Activity (IPAC) 7day questionnaire | x | x | x | x |
| Risk Perception Survey for Developing Diabetes (RPS-DD) | x | x | x | x |
| Health and Wellbeing SF-12 Version 2 | x | x | x | x |
| Edinburgh Postnatal Depression Scale | x | x | x | |
| Motivation to Change Questionnaire | x | x | x | x |
| Exercise Self-Efficacy Questionnaire | x | x | x | x |
TP1, Timepoint1 (32-36 weeks gestation); TP2, Timepoint 2 (6 weeks postpartum); TP3, Timepoint 3 (6 months postpartum); TP4, Timepoint 4, (12 months postpartum).
*Additionally taken initially day 1 postnatal, including fasting glucose, total cholesterol, triglycerides, high density lipoproteins, low density lipoproteins, non-high-density lipoproteins, cholesterol/high density lipoprotein ratio, urea and electrolytes.
** Used daily throughout the 12 months, also includes partners step counts (if applicable).